- Evolution of Radiological Treatment Response Assessments for Cancer Immunotherapy: From iRECIST to Radiomics and Artificial Intelligence
-
Kim N, Lee ES, Won SE, Yang M, Lee AJ, Shin Y, Ko Y, Pyo J, Park HJ, Kim KW
- KMID: 2534421
- Korean J Radiol.
- 2022 Nov;23(11):1089-1101.
- doi: 10.3348/kjr.2022.0225
Immunotherapy has revolutionized and opened a new paradigm for cancer treatment. In the era of immunotherapy and molecular targeted therapy, precision medicine has gained emphasis, and an early response assessment... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Radiological Tumor Response Based on iRECIST and RECIST 1.1 in Metastatic Clear-Cell Renal Cell Carcinoma Patients Treated with Programmed Cell Death-1 Inhibitor Therapy
-
Zheng B, Shin JH, Li H, Chen Y, Guo Y, Wang M
- KMID: 2513107
- Korean J Radiol.
- 2021 Mar;22(3):366-375.
- doi: 10.3348/kjr.2020.0404
Objective: To evaluate the radiological tumor response patterns and compare the response assessments based on immunebased therapeutics Response Evaluation Criteria in Solid Tumors (iRECIST) and RECIST 1.1 in metastatic clear-cell... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of RECIST, PERCIST, EORTC, and MDA Criteria for Assessing Treatment Response with Ga68-PSMA PET-CT in Metastatic Prostate Cancer Patient with Biochemical Progression: a Comparative Study
-
Gupta M, Choudhury , Rawal S, Goel HC, Rao SA
- KMID: 2431979
- Nucl Med Mol Imaging.
- 2018 Dec;52(6):420-429.
- doi: 10.1007/s13139-018-0548-3
PURPOSE: The aim of the study was to compare response evaluation criteria in solid tumours 1.1 (RECIST 1.1), positron emission tomography response criteria in solid tumours (PERCIST), European organisation for... -
- CITED
-
- Close
- SHARE
-
- Close
- Optimal Phase of Dynamic Computed Tomography for Reliable Size Measurement of Metastatic Neuroendocrine Tumors of the Liver: Comparison between Pre- and Post-Contrast Phases
-
Huh J, Park J, Kim KW, Kim HJ, Lee JS, Lee JH, Jeong YK, Shinagare , Ramaiya NH
- KMID: 2424846
- Korean J Radiol.
- 2018 Dec;19(6):1066-1076.
- doi: 10.3348/kjr.2018.19.6.1066
OBJECTIVE: The reliability of size measurements of liver metastases from neuroendocrine tumors (NETs) on contrast-enhanced computed tomography (CT) phases made by different readers may be hampered due to transient, variable... -
- CITED
-
- Close
- SHARE
-
- Close
- Maximum diameter versus volumetric assessment for the response evaluation of vestibular schwannomas receiving stereotactic radiotherapy
-
Choi Y, Kim S, Kwak DW, Lee HS, Kang MK, Lee DK, Hur WJ
- KMID: 2418871
- Radiat Oncol J.
- 2018 Jun;36(2):114-121.
- doi: 10.3857/roj.2018.00031
PURPOSE: To explore the feasibility of maximum diameter as a response assessment method for vestibular schwannomas (VS) after stereotactic radiosurgery or fractionated stereotactic radiotherapy (RT), we analyzed the concordance of... -
- CITED
-
- Close
- SHARE
-
- Close
- Tumor Response Evaluation after Treatment and Post-treatment Surveillance of Hepatocellular Carcinoma
-
Yoon JS, Park SY
- KMID: 2409643
- J Liver Cancer.
- 2018 Mar;18(1):9-16.
- doi: 10.17998/jlc.18.1.9
Hepatocellular carcinoma is one of the most prevalent malignancies and frequent causes of death worldwide. Treatment options of hepatocellular carcinoma consist of locoregional therapy, surgical resection, liver transplantation, and systemic... -
- CITED
-
- Close
- SHARE
-
- Close
- Prediction of response by FDG PET early during concurrent chemoradiotherapy for locally advanced non-small cell lung cancer
-
Kim S, Oh SW, Kim JS, Kim KH, Kim YK
- KMID: 1842050
- Radiat Oncol J.
- 2014 Dec;32(4):231-237.
- doi: 10.3857/roj.2014.32.4.231
PURPOSE: To evaluate the predictive value of the early response of 18F-flurodeoxyglucose positron emission tomography (FDG PET) during concurrent chemoradiotherapy (CCRT) for locally advanced non-small cell lung cancer (NSCLC). MATERIALS AND... -
- CITED
-
- Close
- SHARE
-
- Close
- RECIST Criteria for Tumor Response in the Patients with Breast Cancer Who Had Neoadjuvant Chemotherapy
-
Lee JC, Bae JS, Kim MR, Park WC, Song BJ, Kim JS, Jung SS
- KMID: 2145065
- J Korean Surg Soc.
- 2007 Feb;72(2):89-93.
PURPOSE: This study compared the response evaluation using the WHO (World Health Organization) criteria for patients with breast cancer with that of the RECIST (Response Evaluation Criteria In Solid Tumor)... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of WHO and RECIST Criteria for Response in Metastatic Colorectal Carcinoma
-
Choi JH, Ahn MJ, Rhim HC, Kim JW, Lee GH, Lee YY, Kim IS
- KMID: 2166118
- Cancer Res Treat.
- 2005 Oct;37(5):290-293.
PURPOSE: This study compared the WHO criteria with the response evaluation criteria in solid tumors (RECIST) in the same patients with metastatic colorectal cancer in order to determine the significance... -
- CITED
-
- Close
- SHARE
-
- Close
